Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
S
Sandu Pharmaceuticals Ltd
Score 48/100• Decent
Sandu Pharmaceuticals has a decent growth outlook but faces challenges in valuation and execution risks.
Company’s Health70/100
Valuation 80/100 · PB 1.0291
Technical Avoid
1M -5.376% 6M -11.436% 1Y -19.22%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#196
View details ➜
R
Remedium Lifecare Ltd
Score 48/100• Risky
Remedium Lifecare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health35/100
Valuation 40/100 · PB 3.1349
Technical Avoid
1M 2.041% 6M -15.676% 1Y -62.563%
Confidence100%
No promoter pledge
High debt/equityThin margins
#197
View details ➜
M
Medistep Healthcare Ltd
Score 48/100• Risky
Medistep Healthcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health100/100
Valuation 60/100 · PB 2.1939
Technical Avoid
1M -12.437% 6M -48.361% 1Y -48.361%
Confidence100%
Low leverage (D/E)No promoter pledge
#198
View details ➜
M
Medinova Diagnostic Services Ltd
Score 48/100• Risky
Medinova Diagnostic Services Ltd presents a risky investment due to inconsistent growth and market sentiment.
Company’s Health82/100
Valuation 100/100 · PB -31.7803
Technical Avoid
1M -1.56% 6M -6.401% 1Y 3.922%
Confidence100%
No promoter pledgeHealthy profit margins
#199
View details ➜
Z
Zenotech Laboratories Ltd
Score 48/100• Decent
Zenotech Laboratories Ltd shows potential but faces significant challenges in profitability and market sentiment.
Company’s Health79/100
Valuation 40/100 · PB 3.3959
Technical Avoid
1M 0.952% 6M -5.993% 1Y -34.824%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#200
View details ➜
Z
Zenlabs Ethica Ltd
Score 48/100• Risky
Zenlabs Ethica Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment.
Company’s Health41/100
Valuation 80/100 · PB 1.8675
Technical Avoid
1M -7.656% 6M -8.023% 1Y -27.326%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#201
View details ➜
V
Vista Pharmaceuticals Ltd
Score 48/100• Risky
Vista Pharmaceuticals Ltd shows potential but faces significant risks and challenges in growth and profitability.
Company’s Health38/100
Valuation 80/100 · PB 1.3308
Technical Avoid
1M -4.469% 6M -11.372% 1Y -22.555%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#202
View details ➜
V
Vineet Laboratories Ltd
Score 48/100• Risky
Vineet Laboratories Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment.
Company’s Health29/100
Valuation 60/100 · PB 2.9262
Technical Avoid
1M 24.661% 6M 44.95% 1Y -18.891%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEHigh debt/equity
#203
View details ➜
V
Venus Remedies Ltd
Score 48/100• Risky
Venus Remedies Ltd presents a mixed outlook with significant risks overshadowing its potential growth. Investors should exercise caution.
Company’s Health72/100
Valuation 80/100 · PB 1.035
Technical Avoid
1M -0.978% 6M 43.303% 1Y 39.461%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#204
View details ➜
T
Transgene Biotek Ltd
Score 48/100• Risky
Transgene Biotek Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health46/100
Valuation 60/100 · PB 2.6742
Technical Avoid
1M -6.03% 6M 4.709% 1Y -45.455%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#205
View details ➜
S
Supriya Lifescience Ltd
Score 48/100• Decent
Supriya Lifescience Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised for new investors.
Company’s Health100/100
Valuation 20/100 · PB 6.273
Technical Watch
1M 3.228% 6M 21.704% 1Y 24.603%
Confidence100%
Low leverage (D/E)No promoter pledge
#206
View details ➜
P
Prism Medico and Pharmacy Ltd
Score 48/100• Risky
Prism Medico and Pharmacy Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health39/100
Valuation 100/100 · PB 0.7735
Technical Avoid
1M -17.268% 6M 33.588% 1Y -22.348%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#207
View details ➜
J
JFL Life Sciences Ltd
Score 48/100• Decent
JFL Life Sciences Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health82/100
Valuation 80/100 · PB 1.1539
Technical Avoid
1M 17.073% 6M -29.592% 1Y -37.838%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#208
View details ➜
J
Jeena Sikho Lifecare Ltd
Score 48/100• Risky
Jeena Sikho Lifecare Ltd presents several risks with inconsistent growth and weak profitability metrics, making it a risky investment at this time.
Company’s Health98/100
Valuation 20/100 · PB 33.7818
Technical Avoid
1M -7.516% 6M 71.811% 1Y 112.644%
Confidence100%
Low leverage (D/E)No promoter pledge
#209
View details ➜
S
Syncom Formulations (India) Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health88/100
Valuation 40/100 · PB 4.5003
Technical Avoid
1M 3.222% 6M 1.859% 1Y -18.614%
Confidence100%
Low leverage (D/E)No promoter pledge
#210
View details ➜
Showing 196 to 210 of 301 (21 Pages)